Pages that link to "Q34219375"
Jump to navigation
Jump to search
The following pages link to Probiotics in inflamatory bowel disease (Q34219375):
Displaying 23 items.
- High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease (Q22250942) (← links)
- Diet therapy for inflammatory bowel diseases: The established and the new (Q26768564) (← links)
- Potential and opportunities for use of recombinant lactic acid bacteria in human health (Q33209363) (← links)
- Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. (Q33231186) (← links)
- Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study (Q33426019) (← links)
- The role of bacteria in the pathogenesis of inflammatory bowel disease (Q34206639) (← links)
- Nutritional factors in inflammatory bowel disease (Q34525378) (← links)
- A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease (Q34588311) (← links)
- Probiotics in the management and prevention of atopy (Q34665519) (← links)
- New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age. (Q34984694) (← links)
- Intestinal microflora as a therapeutic target in inflammatory bowel disease (Q35062098) (← links)
- Probiotics and Inflammatory Bowel Disease (Q35128668) (← links)
- Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens (Q35890738) (← links)
- Probiotics: do they have a role in oral medicine and dentistry? (Q36161551) (← links)
- Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk (Q37111200) (← links)
- Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis (Q37320010) (← links)
- Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. (Q37457437) (← links)
- Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells (Q40414006) (← links)
- Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling (Q42704864) (← links)
- Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial (Q43363077) (← links)
- Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background. (Q54431152) (← links)
- Probióticos y enfermedad inflamatoria intestinal (Q57241192) (← links)
- Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice (Q79840083) (← links)